Adiponectin in non-alcoholic steatohepatitis: an ideal culprit, but what are the proofs of its guilt?
Nicolas
N
Lanthier
Isabelle A
IA
Leclercq
D000236:Adenoma / Q000209:etiology / Q000378:metabolism; D052242:Adiponectin / Q000172:deficiency / Q000235:genetics / Q000378:metabolism; D000818:Animals; D004041:Dietary Fats / Q000009:adverse effects*; D004195:Disease Models, Animal; D018450:Disease Progression; D005234:Fatty Liver / Q000209:etiology* / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D006801:Humans; D006949:Hyperlipidemias / Q000209:etiology / Q000378:metabolism; D008099:Liver / Q000378:metabolism* / Q000473:pathology; D008106:Liver Cirrhosis, Experimental / Q000209:etiology* / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D008113:Liver Neoplasms / Q000209:etiology / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D009765:Obesity / Q000209:etiology / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics
D052242:Adiponectin; C499919:Adipoq protein, mouse; D004041:Dietary Fats; D014409:Tumor Necrosis Factor-alpha